ATORVASTATIN-AS atorvastatin (as calcium) 20 mg film-coated tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

atorvastatin calcium, Quantity: 20.68 mg (Equivalent: atorvastatin, Qty 20 mg)

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

Atorvastatin calcium

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; activated attapulgite; microcrystalline cellulose; pregelatinised maize starch; hyprolose; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000

Via di somministrazione:

Oral

Confezione:

10, 20, 40, 50, 30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

As an adjunct to diet for the treatment of patients with hypercholesterolaemia. Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,Indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see CLINICAL TRIALS, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. These effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Dettagli prodotto:

Visual Identification: White, oval bi-convex tablets with breakline on one side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2011-09-16